Clinical and molecular neuro-oncology research (Neuro-Oncology Parallel Session)
Tracks
Strauss 2-3
| Tuesday, October 7, 2025 |
| 8:00 AM - 9:30 AM |
| Strauss 2-3 |
Speakers & Chairs
Prof. Marike Broekman
Neurosurgeon
Haaglanden Medical Center/ Leiden University Medical Center
Chair
Dr. Nikolaos Foroglou
Chair Department
Aristotle University School of Medicine
Chair
Dr. Malte Mohme
Attending Neurosurgeon
University Medical Center Hamburg-eppendorf
Neuro-Immune Crosstalk – Evolutionary immunosuppression in trauma and cancer
8:00 AM - 8:10 AM
Dr Eduardo Erasmo Mendoza Mireles
Specialist
Oslo University Hospital
A International Multicenter Cohort Study of Surgery for Recurrent Brain Metastases (RECMET) – An EANS Section of Neuro-Oncology Initiative
8:10 AM - 8:20 AM
Dr. Salah Eddine Oussama Kacimi
Post-doc
Paris Brain Institute
PCV or temozolomide with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendrogliomas
8:20 AM - 8:30 AM
Prof. Tao Xu
Vice Chairman Of Neurosurgery
Changzheng Hospital
Defect-Engineered 2D Black Ferroelectric Perovskite Nanocatalysts for Augmented Piezocatalytic Glioma Therapy
8:30 AM - 8:37 AM
Dr Manina Etter
Resident
University Hospital
Combating Glioblastoma: Enhancing anti-EGFRvIII CAR T Cell Therapy with a Paracrine SIRP -derived CD47 Blocker – A Proof-of-Concept Preclinical Study Translating into a First-in-Human Phase I Clinical Trialac
8:37 AM - 8:44 AM
Dr Jonas Ort
Resident
Rwth Aachen University
Glioblastoma cell infiltration induces neuronal hyperexcitability and alters peritumoral network connectivity properties in an in-vitro model of human brain slice cultures.
8:44 AM - 8:51 AM
Prof. Marian Christoph Neidert
Deputy Chairman
Kantonsspital St.gallen
The Intra-humoral Heterogeneity of the Antigenic Landscape in Glioblastoma
8:51 AM - 8:58 AM
Mr Timo Schenker
Resident
University Hospital Basel
Development of CAR Macrophages and CAR Microglia as a Novel Treatment Against Glioblastoma
8:58 AM - 9:05 AM
Mr Charles Champeaux Depond
Consultant Neurosurgeon
Clairval Private Hospital
Overall survival after carmustine wafers implantation for newly-diagnosed high grade glioma. A nationwide population-based controlled propensity score-matched analysis.
9:05 AM - 9:12 AM
Dr. Jordina Rincon-Torroella
Dr
Johns Hopkins
Glucagon-Like Peptide-1 Receptor Agonists and Primary Malignant Brain Tumor Risk in Type 2 Diabetes
9:12 AM - 9:19 AM
Discussion
Discussion
9:19 AM - 9:30 AMChairperson
Marike Broekman
Neurosurgeon
Haaglanden Medical Center/ Leiden University Medical Center
Nikolaos Foroglou
Chair Department
Aristotle University School of Medicine
Presenter
Charles Champeaux Depond
Consultant Neurosurgeon
Clairval Private Hospital
Manina Etter
Resident
University Hospital
Salah Eddine Oussama Kacimi
Post-doc
Paris Brain Institute
Eduardo Erasmo Mendoza Mireles
Specialist
Oslo University Hospital
Malte Mohme
Attending Neurosurgeon
University Medical Center Hamburg-eppendorf
Marian Christoph Neidert
Deputy Chairman
Kantonsspital St.gallen
Jonas Ort
Resident
Rwth Aachen University
Jordina Rincon-Torroella
Dr
Johns Hopkins
Timo Schenker
Resident
University Hospital Basel
Tao Xu
Vice Chairman Of Neurosurgery
Changzheng Hospital
